ArticleJournal of epidemiology and global health2022
Systematic Analysis of the Global, Regional and National Burden of Cardiovascular Diseases from 1990 to 2017.
Article in Journal of epidemiology and global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Impact of interventions targeting social isolation and loneliness for older adults with cardiovascular disease: a systematic review.BMC public health · 2026Pooled it
- Understanding Drug Interactions in Antiplatelet Therapy for Atherosclerotic Vascular Disease: A Systematic Review.CNS neuroscience & therapeutics · 2025Pooled it
- Association between Wine Consumption with Cardiovascular Disease and Cardiovascular Mortality: A Systematic Review and Meta-Analysis.Nutrients · 2023Pooled it
- The Impact ofNutrients · 2024Trial
- Bilibili and TikTok heart failure short video evaluation: a cross-sectional study.Scientific reports · 2026Article
- Development and validation of an interpretable machine learning model for predicting 5-year major adverse cardiovascular events in patients with coronary artery disease.BMC cardiovascular disorders · 2026Article
- Motives Influencing Arab Students' Preference for Cardiology: A Cross-sectional Multicenter Study.Annals of African medicine · 2026Article
- Article
- Upregulation and diagnostic potential of Interleukin-36 cytokine isoforms in dilated cardiomyopathy: evidence from human and murine models.Molecular biology reports · 2025Article
- Bioinformatic analyses and validated experiments reveal an aging hallmark gene set and protective miR of coronary artery disease.Scientific reports · 2025Article
- Transesophageal echocardiography: Revolutionizing perioperative cardiac care.Biomolecules & biomedicine · 2025Review
- Burden of Hypertensive Heart Disease and Its Risk Factors in East Asia, 1990-2021: Findings From the Global Burden of Disease Study 2021.Global heart · 2025Article
- Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research: A Scoping Review and Translational Prospects.Molecules (Basel, Switzerland) · 2024Article
- Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States.BMC public health · 2024Article
- Resilience and its influencing factors after emergency percutaneous coronary intervention in young and middle-aged patients with first acute myocardial infarction.Scientific reports · 2024Article
- Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019.European heart journal. Quality of care & clinical outcomes · 2024Article
- Identification of Novel and Recurrent Variants inJournal of clinical medicine · 2024Article
- Diagnostic Accuracy of Waist-to-Height Ratio, Waist Circumference, and Body Mass Index in Identifying Metabolic Syndrome and Its Components in Older Adults: A Systematic Review and Meta-Analysis.Current developments in nutrition · 2024Article
- Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies on the burden of cardiovascular diseases (CVDs) were mainly based on limited data of the study period or area, or did not include detailed risk factor analysis.
objectiveTo investigate up-to-date temporal and regional trends and risk factors of mortality and disability-adjusted life years (DALYs) attributed to CVDs by age, sex, and disease throughout the world.
methodsData for the disease burden of CVDs in 195 countries and territories from 1990 to 2017, including mortality, DALYs, age-standardized mortality rates, and age-standardized DALY rates, were estimated from the Global Burden of Disease Study 2017. Risk factors attributable to deaths and DALYs for CVDs were also estimated using the comparative risk assessment framework.
resultsThe number of deaths from CVDs increased by 48.62%, from 11.94 (95% UI 11.78-12.18) million in 1990 to 17.79 (17.53-18.04) million in 2017. However, the age-standardized mortality rate decreased by an average of - 1.45% (- 1.72% to - 1.18%) annually. After fluctuation in the expected age-standardized mortality rate of CVDs in most of the socio-demographic index (SDI) scale, these rates decrease rapidly for SDI values of 0.7 and higher. In 2017, metabolic risks accounted for 73.48% of deaths and 73.25% of DALYs due to CVDs, behavioral factors accounted for 63.23% of deaths and 66.71% of attributable DALYs.
conclusionCVDs remain a major global health burden due to the increment in death numbers and DALYs. Aging and the main risk factors are the main drivers of mortality and health loss. More attention to main risk factors should be paid with supportive health policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.